Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1.
about
A review on carrier systems for bone morphogenetic protein-2Adenoviral Delivery of the VEGF and BMP-6 Genes to Rat Mesenchymal Stem Cells Potentiates Osteogenesis.Emerging ideas: treatment of precollapse osteonecrosis using stem cells and growth factors.Combined VEGF and LMP-1 delivery enhances osteoprogenitor cell differentiation and ectopic bone formation.Osteogenic response of human adipose-derived stem cells to BMP-6, VEGF, and combined VEGF plus BMP-6 in vitro.Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo.Emulating native periosteum cell population and subsequent paracrine factor production to promote tissue engineered periosteum-mediated allograft healingControlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.Strategies to Stimulate Mobilization and Homing of Endogenous Stem and Progenitor Cells for Bone Tissue Repair.In vitro and long-term (2-year follow-up) in vivo osteogenic activities of human periosteum-derived osteoblasts seeded into growth factor-releasing polycaprolactone/pluronic F127 beads scaffolds.Osteo-/odontogenic differentiation of BMP2 and VEGF gene-co-transfected human stem cells from apical papilla.Potentiated Osteoinductivity via Cotransfection with BMP-2 and VEGF Genes in Microencapsulated C2C12 CellsThe role of bone marrow mesenchymal stem cells in the treatment of acute liver failure.Evaluation of adenoviral vascular endothelial growth factor-activated chitosan/hydroxyapatite scaffold for engineering vascularized bone tissue using human osteoblasts: In vitro and in vivo studies.Exogenously added BMP-6, BMP-7 and VEGF may not enhance the osteogenic differentiation of human adipose stem cells.
P2860
Q28271739-72E54E78-696A-4249-9341-5D3262365AAFQ30421765-0B3B1297-4573-45C5-8A76-1596AEEC8C41Q30425130-0CDD66DB-0786-4407-B001-D4ABF4CA0115Q30452672-E506EA8E-1132-46A1-B796-650E1DC4B075Q30456161-D5255FE5-50B3-477C-840C-1E6D2053FA09Q33557502-D4E16E1C-764C-4052-9EF5-1A8C2FC46658Q35232478-D2045079-1A03-459C-A807-E4F811163933Q38068244-A2C14141-0113-4895-BAB0-206C89A5233CQ38530142-7A13B9C8-ACC2-4BCF-AE12-5CEFA128A3A6Q39374856-108F4A4C-624F-4F10-BA0C-B4A16FDD68D6Q40396000-6B1C9E3C-ED5E-4199-8035-97B205D975D2Q41604071-B8A99606-7694-48FD-9A47-BD83ACAE63B3Q41912777-14EA6135-DB13-457D-A3F2-443CA49A1EA3Q42203734-65B26AA7-EAD6-4B73-B853-9B3A77D976E2Q44624517-86EAF668-6B50-46BF-9507-DA96BBE11160
P2860
Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Enhancement of bone formation ...... MP-2, VEGF and angiopoietin-1.
@en
Enhancement of bone formation ...... MP-2, VEGF and angiopoietin-1.
@nl
type
label
Enhancement of bone formation ...... MP-2, VEGF and angiopoietin-1.
@en
Enhancement of bone formation ...... MP-2, VEGF and angiopoietin-1.
@nl
prefLabel
Enhancement of bone formation ...... MP-2, VEGF and angiopoietin-1.
@en
Enhancement of bone formation ...... MP-2, VEGF and angiopoietin-1.
@nl
P2860
P50
P1476
Enhancement of bone formation ...... BMP-2, VEGF and angiopoietin-1
@en
P2093
Hongliang Hou
Kerong Dai
P2860
P2888
P304
P356
10.1007/S10529-009-0007-4
P577
2009-04-24T00:00:00Z